Glioblastoma is an aggressive form of a brain tumor that may be treated entirely differently in the future based on a clinical trial set to being soon.
Unfortunately, the prognosis of glioblastoma is quite grim for many with a life expectancy of 1-3 years on average with most losing their fight within the first 12 months.
New studies however surrounding cannabis and different forms of progressive tumors and cancers are giving hope to the hundreds of individuals diagnosed with glioblastoma annually.
One such study is the world's first ever clinical trial utilizing medical cannabis to treat glioblastoma. Researchers for this study are set to begin accepting volunteers mid-November.
The study will be based out of Australia and led by Neurosurgeon Charlie Teo, and Dr. Janet Schloss whom is a nutritionist and naturopath specialist at The Endeavour College of Natural Health.
While their research will focus on determining if high potency cannabis oil can aid other cancer treatments in reducing tumor sizes, their specific focus will be whether or not THC can help to reduce tumor regrowth in patients with glioblastoma.
Here are some facts regarding glioblastoma per the American Brain Tumor Association.
As you can see, research on treatment options that could potentially change the prognosis of glioblastoma is crucial. In fact, it could mean the difference between life and death for hundreds of people each year.
It is exciting to see that new research studies and especially clinical trials such as these are starting to unfold in new places globally each year. There are countless anecdotal stories of high potency cannabis oils such as RSO not only putting people’s cancer in remission but demolishing it entirely.
There are also scientific studies that support the theory that THC could not only help reduce the size of tumors but could potentially prevent regrowth in aggressive tumors such as glioblastoma where the cancerous cells are in a constant state of division and regrowth.
If you or someone you know have been diagnosed with glioblastoma and would like to participate in this study, contact information is as follows;
Email: firstname.lastname@example.org Phone:(07) 3253 9582
It will be remarkable to see the conclusions of this clinical studies once it is thoroughly performed. Once results are available, you can be sure that Roottie will be following up on this story and the results of the world’s first ever clinical trial utilizing medical cannabis for glioblastoma.Posted: Saturday, November 3rd, 10:00am 12 days ago
Ashley is a freelance cannabis writer and the co-owner of CannaLance. Her passion for sharing education and truth surrounding cannabis stems from a personal loss. Ashley has always had an elevated relationship with cannabis but it wasn't until 2015 that she turned that passion and relationship into a career as a cannabis writer.